Protection by opioid ligands against modification of the opioid receptor by a carbodiimide
- 1 April 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (7) , 1415-1419
- https://doi.org/10.1016/0006-2952(92)90197-q
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Control of bacteriorhodopsin color by chloride at low pHBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1990
- Differential labeling of the catalytic subunit of cAMP-dependent protein kinase with a water-soluble carbodiimide: identification of carboxyl groups protected by magnesium ATP and inhibitor peptidesBiochemistry, 1990
- A Single Amino Acid Substitution in the β-Adrenergic Receptor Promotes Partial Agonist Activity from AntagonistsJournal of Biological Chemistry, 1989
- PD117302: a selective agonist for the κ‐opioid receptorBritish Journal of Pharmacology, 1988
- Ligand binding to the β-adrenergic receptor involves its rhodopsin-like coreNature, 1987
- Distinct Subtypes of the Opioid Receptor with Allosteric Interactions in Brain MembranesJournal of Neurochemistry, 1986
- Opioid binding sites of the κ-type in guinea-pig cerebellumNeuroscience, 1984
- The binding spectrum of narcotic analgesic drugs with different agonist and antagonist propertiesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1982
- COMPARISON OF THE BINDING CHARACTERISTICS OF TRITIATED OPIATES AND OPIOID PEPTIDESBritish Journal of Pharmacology, 1980
- A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samplesAnalytical Biochemistry, 1978